This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these messages)
|
Janusz Jankowski | |
---|---|
Born | |
Nationality | British |
Alma mater | University of Glasgow University of Dundee University of London University of Oxford |
Known for |
|
Scientific career | |
Fields | Clinical Trials Gastroenterology Genomics Health promotion Education Academic Administration |
Janusz Jankowski is a doctor, educationalist and scientist of Scottish Polish origin. [1] He is an expert in Social and Healthcare Policy, Academic Management and Global Research and Education Networks. [2] He was formerly in previous senior management roles including Deputy Vice Chancellor of Research and Innovation, [3] Pro Vice Chancellor Research, Vice Dean Research and the Sir James Black Professorship. [4] He is father to three children, including son and Semi-Pro hockey player Jakob Jankowski.
Jankowski was educated at Hillhead High School, Glasgow a state co-educational school. He graduated from the University of Glasgow with a Baccalaureate in Medicine and Surgery (1983), the University of Dundee for a Doctorate of Medicine in Molecular Medicine (1996), [5] a Doctorate of Philosophy in Molecular Genetics at the Royal Postgraduate Medical School, Imperial College at the University of London (1996) and at the University of Oxford gaining a Masters in Epidemiology and Clinical Trials (2009). [6]
Jankowski has held Professorships at the University of Birmingham, University of Leicester Queen Mary University of London and has been a Visiting Professor and then the Sir James Black Senior Fellow at the University of Oxford. [7] He has been the Associate Dean for Research at the Plymouth University Peninsula Schools of Medicine and Dentistry, and then as Pro Vice Chancellor Research, University of Central Lancashire and briefly on a part-time basis as Deputy Vice Chancellor for Research and Innovation at RCSI. [8] He was also Consultant Gastroenterologist and Lead Mentor at the University Hospitals of Morecambe Bay NHS Foundation Trust. [9] [10] Over 20 years he has raised £120m+ in funds. [11]
Jankowski had a senior management contribution to the Research Excellence Framework 2014 as the Clinical Medicine (UoA1) Lead for the Plymouth University Peninsula Schools of Medicine and Dentistry (PUPSMD). [12]
Jankowski is an expert in reflux esophagitis, Barrett's esophagus, acute medicine and clinical trials as well as in cancer prevention and health promotion. As a clinician, Jankowski has created centres of excellence in medicine including the Digestive Disease Centre, University Hospitals of Leicester 2002–2012. [13] He also set up Scotland's endoscopic surveillance service for Barrett's esophagus (ESBE) between 1988 and 1991 at Ninewells Hospital of Dundee. [14]
Jankowski has published independent guidance for the National Health Service (NHS) and other international organisations using the Delphi systematic review platforms. [15]
Jankowski was an editor of text books in gastroenterology and gastrointestinal cancer. [16]
Jankowski's group have undertaken several studies including the isolation of label retaining cells (putative stem cells) in the oesophagus, [17] identification of the genomic factors associated with the premalignant condition Barrett's oesophagus. [18] Jankowski has studied the use of aspirin and proton pump inhibitors in one of the largest randomized clinical trials to prevent cancer. [19] [20] [21] Jankowski is a highly cited clinical academic with a h-index of over 65. [22] He has over 200 publications of which 150 are peer reviewed papers including in Gastroenterology , The Lancet , Lancet Oncology , Nature , Nature Genetics , Nature Communications , New England Journal of Medicine and Proceedings of the National Academy of Sciences USA. [23]
Jankowski has been awarded NHS Clinical Excellence Awards, the Sir Francis Avery Jones Award (British Society of Gastroenterology), [24] the James Black Senior Fellowship (University of Oxford) and Lectureship (Brasenose College) [25] and the Sir James Black Professorship (Plymouth University). [26]
Jankowski is a Tae Kwon Do 1st Dan black belt. [27] [28] He has been a parish councillor. [29] Jankowski has been chair of the Acute and Chronic Diseases Panel of NICE, chair the GI Cancer Prevention Committee of the National Cancer Research Network and chair of the Education Committee of the British Society of Gastroenterology. [30] Jankowski is currently chair of the European Union TRANSCAN-2 committee. [31] Between July 2019 and June 2022 he was chair of the board of directors at University College of Osteopathy.
Gastroenterology is the branch of medicine focused on the digestive system and its disorders. The digestive system consists of the gastrointestinal tract, sometimes referred to as the GI tract, which includes the esophagus, stomach, small intestine and large intestine as well as the accessory organs of digestion which include the pancreas, gallbladder, and liver.
Proton-pump inhibitors (PPIs) are a class of medications that cause a profound and prolonged reduction of stomach acid production. They do so by irreversibly inhibiting the stomach's H+/K+ ATPase proton pump.
The esophagus, oesophagus, or œsophagus all ; pl.: ( e)(œ)sophagi or (œ)sophaguses), colloquially known also as the food pipe, food tube, or gullet, is an organ in vertebrates through which food passes, aided by peristaltic contractions, from the pharynx to the stomach. The esophagus is a fibromuscular tube, about 25 cm (10 in) long in adults, that travels behind the trachea and heart, passes through the diaphragm, and empties into the uppermost region of the stomach. During swallowing, the epiglottis tilts backwards to prevent food from going down the larynx and lungs. The word oesophagus is from Ancient Greek οἰσοφάγος (oisophágos), from οἴσω (oísō), future form of φέρω + ἔφαγον.
Esophageal achalasia, often referred to simply as achalasia, is a failure of smooth muscle fibers to relax, which can cause the lower esophageal sphincter to remain closed. Without a modifier, "achalasia" usually refers to achalasia of the esophagus. Achalasia can happen at various points along the gastrointestinal tract; achalasia of the rectum, for instance, may occur in Hirschsprung's disease. The lower esophageal sphincter is a muscle between the esophagus and stomach that opens when food comes in. It closes to avoid stomach acids from coming back up. A fully understood cause to the disease is unknown, as are factors that increase the risk of its appearance. Suggestions of a genetically transmittable form of achalasia exist, but this is neither fully understood, nor agreed upon.
Heartburn, also known as pyrosis, cardialgia or acid indigestion, is a burning sensation in the central chest or upper central abdomen. Heartburn is usually due to regurgitation of gastric acid into the esophagus. It is the major symptom of gastroesophageal reflux disease (GERD).
Gastroesophageal reflux disease (GERD) or gastro-oesophageal reflux disease (GORD) is a chronic upper gastrointestinal disease in which stomach content persistently and regularly flows up into the esophagus, resulting in symptoms and/or complications. Symptoms include dental corrosion, dysphagia, heartburn, odynophagia, regurgitation, non-cardiac chest pain, extraesophageal symptoms such as chronic cough, hoarseness, reflux-induced laryngitis, or asthma. In the long term, and when not treated, complications such as esophagitis, esophageal stricture, and Barrett's esophagus may arise.
Barrett's esophagus is a condition in which there is an abnormal (metaplastic) change in the mucosal cells lining the lower portion of the esophagus, from stratified squamous epithelium to simple columnar epithelium with interspersed goblet cells that are normally present only in the small intestine and large intestine. This change is considered to be a premalignant condition because of its potential to further transition to esophageal adenocarcinoma, an often-deadly cancer.
An endoscopy is a procedure used in medicine to look inside the body. The endoscopy procedure uses an endoscope to examine the interior of a hollow organ or cavity of the body. Unlike many other medical imaging techniques, endoscopes are inserted directly into the organ.
A hiatal hernia or hiatus hernia is a type of hernia in which abdominal organs slip through the diaphragm into the middle compartment of the chest. This may result in gastroesophageal reflux disease (GERD) or laryngopharyngeal reflux (LPR) with symptoms such as a taste of acid in the back of the mouth or heartburn. Other symptoms may include trouble swallowing and chest pains. Complications may include iron deficiency anemia, volvulus, or bowel obstruction.
Esophageal cancer is cancer arising from the esophagus—the food pipe that runs between the throat and the stomach. Symptoms often include difficulty in swallowing and weight loss. Other symptoms may include pain when swallowing, a hoarse voice, enlarged lymph nodes ("glands") around the collarbone, a dry cough, and possibly coughing up or vomiting blood.
Nutcracker esophagus, jackhammer esophagus, or hypercontractile peristalsis, is a disorder of the movement of the esophagus characterized by contractions in the smooth muscle of the esophagus in a normal sequence but at an excessive amplitude or duration. Nutcracker esophagus is one of several motility disorders of the esophagus, including achalasia and diffuse esophageal spasm. It causes difficulty swallowing (dysphagia) with both solid and liquid foods, and can cause significant chest pain; it may also be asymptomatic. Nutcracker esophagus can affect people of any age but is more common in the sixth and seventh decades of life.
Hashem B. El-Serag is a Palestinian-American physician and medical researcher best known for his research in liver cancer, hepatocellular carcinoma (HCC) and the hepatitis C virus. He serves as the Margaret M. and Albert B. Alkek Chairman of the Department of Medicine at Baylor College of Medicine as well as the co-director of the Texas Medical Center Digestive Disease Center. El-Serag previously served as president of the American Gastroenterological Association and Editor-in-Chief of Clinical Gastroenterology and Hepatology.
Michael John Godfrey Farthing is British emeritus professor at the University of Sussex, where he was previously its vice-chancellor (2007–2016). His early academic career was in medicine, specialising in gastroenterology.
Norman Rupert Barrett CBE FRSA was an Australian-born British thoracic surgeon who is widely yet mistakenly remembered for describing what became known as Barrett's oesophagus.
Therapeutic endoscopy is the medical term for an endoscopic procedure during which treatment is carried out via the endoscope. This contrasts with diagnostic endoscopy, where the aim of the procedure is purely to visualize a part of the gastrointestinal, respiratory or urinary tract in order to aid diagnosis. In practice, a procedure which starts as a diagnostic endoscopy may become a therapeutic endoscopy depending on the findings, such as in cases of upper gastrointestinal bleeding, or the finding of polyps during colonoscopy.
Oesophagogastric junctional adenocarcinoma is a cancer of the lower part of the oesophagus with a rising incidence in Western countries. This disease is often linked to Barrett's oesophagus.
Rebecca Clare Fitzgerald is a British medical researcher who studies cancer evolution to find new ways to detect and prevent cancer, with a particular focus on oesophageal cancer. She is a tenured Professor of Cancer Prevention and is the founding Director at the Early Cancer Institute of the University of Cambridge.
Sharmila Anandasabapathy is a Sri Lankan-American physician and researcher in the field of gastrointestinal cancer. She is a professor of medicine in gastroenterology and serves as director of Baylor Global Health and vice president at the Baylor College of Medicine.
Prateek Sharma is an Indian American gastroenterologist that specializes in esophageal diseases and endoscopic treatments.
Deirdre Anne Kelly is an Irish clinician, academic, and author. She is Professor of Paediatric Hepatology at the University of Birmingham and Clinical Lead for National Paediatric Hepatitis C Operational Delivery Network. She chairs the Board of Pension Trustees at the General Medical Council and is a non-executive director at NHS Blood and Transplant.